Navigation Links
NDA Partners Appoints Ellen Teplitzky, JD as Director of its Legal Services Practice
Date:10/20/2014

Rochelle, Virginia (PRWEB) October 20, 2014

Earle Martin, Chief Executive Officer of NDA Partners LLC, announced today that Ellen Teplitzky, an experienced attorney specializing in business matters and legal support for the pharmaceutical industry, has joined the firm as Director of Legal Services and manager of its legal services practice. NDA Partners provides legal services, including research, expert reports and expert witness and testimony, to top law firms and their clients in cases involving complex issues such as product liability, patent infringement, generic competition, and regulatory agency process. The firm’s expert consultants are some of the most respected and accomplished pharmaceutical scientists and industry executives in the world, including former senior executives from the US Food and Drug Administration (FDA), EU regulatory agencies, and major pharmaceutical companies.

“Ms. Teplitzky brings a level of knowledge and experience to our legal practice that will greatly benefit the law firms we work with and their clients,” said Mr. Martin. “These cases are very complex and demanding, and require a deep understanding of the process and issues. Ms. Teplitzky’s support for our legal engagements will further our goal of providing the high quality services and support that our clients expect.”

Ms. Teplitzky has prior experience as Vice President of Legal Affairs at Aptiv Solutions, a contract research organization (CRO); legal counsel at Clinical Transfer Technology Group, a law firm specializing in legal services for pharmaceutical and biotechnology clients; Director of Contracts & Legal Affairs at PRA International, an international CRO; and Corporate Counsel Consultant with Lexis-Nexis. She was awarded her LLM degree from King’s College (London, England) with Merit, JD degree from Emory University School of Law (Atlanta, GA), and received a BA in History at Emory College.

About NDA Partners
NDA Partners is a strategy consulting firm specializing in expert product development and regulatory advice to the medical products industry and associated service industries such as law firms, investment funds and government research agencies. The highly experienced Principals and Premier Experts of NDA Partners include two former FDA Center Directors; the former Chairman of the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK; an international team of approximately 40 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and virtual product development teams.

Read the full story at http://www.prweb.com/releases/2014/10/prweb12255769.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
2. Dicom Systems and USARAD.com Announce Partnership and Introduce Beta Version of XMRI.com, New System by USARAD.com
3. Palatin Technologies to Present at Windhovers Therapeutic Area Partnerships Conference
4. Van Andel Institute Partners with UNCF to Recruit Students to Biomedical Research Careers
5. BioStorage Technologies Partners with Susan G. Komen for the Cure Tissue Bank at IU Simon Cancer Center to Raise Money and Awareness for Breast Cancer Research
6. Cowen Healthcare Royalty Partners Raises $1 Billion
7. Life Technologies Partners With DaAn Gene to Develop and Commercialize Molecular Diagnostic Assays in China
8. CoreLab Partners Opens Office in Tokyo, Japan
9. Unigene Receives 2012 Drug Delivery Partnerships Industry Achievement Award
10. JBT Corporation and Swisslog Enter Into Partnership for Automated Guided Vehicles
11. RiverVest Venture Partners Sells Four Successful Life Science Companies for More than $1 Billion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... , ... April 24, 2017 , ... ... thermal denaturation in a cellular milieu; however, the broad application of this cellular ... simple platforms with sensitive quantitative readouts. Cell-based thermal stabilization assays are valuable methods ...
(Date:4/21/2017)... ... April 21, 2017 , ... The University of Connecticut, ... funding to three startups through the UConn Innovation Fund. The $1.5 million UConn ... affiliated with UConn. , The UConn Innovation Fund provides investments of up to ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... nourishing a range of emerging technology-based businesses, recently earned a $77,518 grant from ... , Founded in 2004, FITCI is Frederick’s first incubator. A non-profit corporation, ...
(Date:4/20/2017)... ... April 20, 2017 , ... USDM Life Sciences , ... sciences and healthcare industries, is pleased to announce Holger Braemer as Vice ... “USDM Europe GmbH” based in Germany. , Braemer is an integral part of ...
Breaking Biology Technology:
(Date:4/11/2017)... MELBOURNE, Florida , April 11, 2017 ... "Company"), a security technology company, announces the appointment of independent ... John Bendheim to its Board of Directors, furthering the ... ... behalf of NXT-ID, we look forward to their guidance and ...
(Date:4/5/2017)... , April 5, 2017 Today ... announcing that the server component of the HYPR platform ... for providing the end-to-end security architecture that empowers biometric ... HYPR has already secured over 15 million users ... including manufacturers of connected home product suites and physical ...
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
Breaking Biology News(10 mins):